Le Lézard
Classified in: Health
Subjects: PDT, BFA

SafeCheck USA Body Temperature Detectors Launches the MP2-L & MP3 Models


MIAMI, July 20, 2020 /PRNewswire/ -- SafeCheck USA today announced the launch  of its SafeCheck MP2-L & MP3 model. SafeCheck's new models instantly reads the body temperature accurately of an individual by placing one's wrist or forehead up to 9 inches from the sensors.

SafeCheck's new models can screen individuals as young as 3 years old, that makes it ideal for schools, amusement parks and any public environment.

The MP2-L has 2 sensors one located at 5 feet another located at 3 feet high. The width of the MP2-L has been extended to 39 inches from panel to panel, that makes it ADA accessible.

The MP3 model has been designed to cater to facilities that have existing metal detectors and who would like to add temperature screening to convert it into one check point. The MP3 model does not display the temperature reading, it is a fail or pass solution indicating with a green light when the temperature is under 100.4F (adjustable) and red light when the temperature is above the threshold.

SafeCheck USA new models are both very efficient with a capability of screening up to 70 people per minute. Both reliable, durable and robust. The units could be used indoors and outdoors in a temperature ranging from -4F to 113F and still provide an accurate reading with a small error margin of 0.54F

A SafeCheck spoke person said the world is changing rapidly and we are adapting our models to the CDC and HIPPA guidelines of the new normal.

SafeCheck has quickly became a reference in infrared temperature screening technology.              

For more information, visit https://safecheckusa.com

Media Contact
SafeCheck USA
Powered by NDW Holdings LLC
20200 W Dixie Highway, Suite 1102,
Miami, FL33180
+ 646-789-4500
[email protected] 

 

SOURCE SafeCheck USA


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: